NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM2486549 Query DataSets for GSM2486549
Status Public on Sep 14, 2017
Title sample.12.B_pre-BE
Sample type RNA
 
Source name pre-BE
Organism Homo sapiens
Characteristics subject status: patients with Barrett's oesophagus who underwent APC ablation of their Barrett's mucosa
tissue: pre-ablation Barrett's mucosa
percentage of barrett's at 3-5 years: N/A
molecule subtype: microRNA
Treatment protocol Musocal biopsy samples were collected from patients with Barrett's oesophagus or healthy controls. After collection, they were immediately stored in RNAlater® solution (Ambion, Austin, Texas, USA) as the manufacturer’s protocol indicated
Extracted molecule total RNA
Extraction protocol After the biopsies were thawed and extra RNAlater@ solution removed, the samples were homogenized in 500 ul TRIzol@ Reagent (Invitrogen, Carlsbad, CA, USA) and the manufacturer's protocol was followed to extract RNA. The RNA concentration was determined using the Biophotometer.
Label FAMTM
Label protocol PCR assays were performed by following the protocol for TaqMan@OpenArray Human MicroRNA Panel (4461104, Life technologies). 45 ng of RNA was used in the reverse transciption reaction for each sample. Megaplex Primer pools, Human Pools set v3.0 was used in the assay.
 
Hybridization protocol n/a
Scan protocol n/a
Data processing Raw fluorescence data was processed using OpenArray® Real-Time qPCR Analysis Software (BioTrove™, version 1.0.4). Raw fluorescence data was exported in .csv file format for subsequent processing in R software.
The CSV files were imported into R software (3.1.0) and the fractional cycle (Ct) at which the second derivative maximum of a logistic curve fit to the raw fluorescence data was determined. Any microRNA that had no Ct value for a particular sample was assigned the value of 40.
Mann Whitney U tests were used to generate lists of differentially expressed microRNAs in the comparison of control squamous tissues vs post-ablation neosquamous tissues, and for the comparison of post-ablation squamous tissues vs. post-ablation neosquamous tissues. Significance was set at p<0.05.
False Discovery rates were estimated using the Benjamini-Hochberg procedure (Benjamini, Yoav; Hochberg, Yosef (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing (PDF). Journal of the Royal Statistical Society, Series B. 57 (1): 289–300.)
Fold Change worksheet reports the the ratios of normalized relative expression levels.
 
Submission date Feb 14, 2017
Last update date Sep 14, 2017
Contact name Damian James Hussey
E-mail(s) damian.hussey@flinders.edu.au
Organization name Flinders University
Street address Flinders Drive
City Bedford Park
ZIP/Postal code 5042
Country Australia
 
Platform ID GPL17485
Series (1)
GSE94854 The microRNA profile in neosquamous oesophageal mucosa following ablation of Barrett's oesophagus

Data table header descriptions
ID_REF
VALUE normalized relative levels

Data table
ID_REF VALUE
000604_hsa-miR-424 3.309551958
002332_hsa-miR-409-3p 1.039446138
002261_hsa-miR-135b 1.097022076
002279_hsa-miR-31 1.039217926
000460_hsa-miR-135a 1.393148854
001193_mmu-miR-187 0.00245572
002098_hsa-miR-223# 0.003401638
002122_hsa-miR-376c 0.92274597
002293_hsa-miR-214# 0.957301811
000452_hsa-miR-127 1.513441955
002100_hsa-miR-136# 1.888728488
000498_hsa-miR-199a 1.068447017
002113_hsa-miR-31# 1.268668081
000545_hsa-miR-331 0.974675633
001551_hsa-miR-597 0.353219557
002309_hsa-miR-424# 1.933466126
001610_hsa-miR-411 0.565868928
000426_hsa-miR-34a 0.554096961
000456_hsa-miR-130b 1.487336614
002215_hsa-miR-196b 0.807509606

Total number of rows: 750

Table truncated, full table size 23 Kbytes.




Supplementary data files not provided
Processed data included within Sample table
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap